The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Zispin SolTab 30mg orodispersible tablet

30 milligram(s) Orodispersible tablet

Merck Sharp & Dohme Ireland (Human Health) LimitedPA1286/047/002

Main Information

Trade NameZispin SolTab 30mg orodispersible tablet
Active SubstancesMirtazapine
Strength30 milligram(s)
Dosage FormOrodispersible tablet
Licence HolderMerck Sharp & Dohme Ireland (Human Health) Limited
Licence NumberPA1286/047/002

Group Information

ATC CodeN06AX Other antidepressants
N06AX11 mirtazapine

Status

Authorised/WithdrawnAuthorised
Licence Issued21/02/2003
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0061-033-015
Interchangeable List DocumentPDF of Interchangeable List
« Back